Technical Analysis for LLY - Eli Lilly and Company

Grade Last Price % Change Price Change
grade C 140.83 -0.13% -0.18
LLY closed down 0.13 percent on Wednesday, February 19, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical LLY trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -0.13%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.13%
Doji - Bullish? Reversal -0.13%
Down 3 Days in a Row Weakness -0.13%
Down 4 Days in a Row Weakness -0.13%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; bipolar depression and treatment-resistant depression; and brain imaging of beta-amyloid plaques. Its endocrinology products treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. The company's oncology products treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as cardiovascular products, which are used treat erectile dysfunction, benign prostatic hyperplasia, high cholesterol, pulmonary arterial hypertension; reduce thrombotic cardiovascular events; and used as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; products to treat canine separation anxiety; products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections; and other pharmaceutical products to treat staphylococcal and bacterial infections. The company distributes its products through independent wholesale distributors; and directly to pharmacies. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Diabetes Pharmaceutical Products Neuroscience Schizophrenia Antibiotics Pulmonary Arterial Hypertension Animal Health Products Psychiatric Diagnosis Psychiatry Major Depressive Disorder Attention Deficit Hyperactivity Disorder Depression Wholesale Distributors Benign Prostatic Hyperplasia Obsessive Compulsive Disorder Osteoporosis Cardiovascular Products Bipolar Disorder Depressive Disorder Erectile Dysfunction Head And Neck Cancers Major Depressive Disorders Oncology Products Bulimia Nervosa High Cholesterol Psychology Respiratory And Other Diseases Testosterone Deficiency Treatment Resistant Depression

Is LLY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 147.87
52 Week Low 101.36
Average Volume 3,398,322
200-Day Moving Average 118.33
50-Day Moving Average 135.56
20-Day Moving Average 142.29
10-Day Moving Average 143.91
Average True Range 2.30
ADX 36.16
+DI 24.08
-DI 24.09
Chandelier Exit (Long, 3 ATRs ) 140.97
Chandelier Exit (Short, 3 ATRs ) 144.24
Upper Bollinger Band 147.55
Lower Bollinger Band 137.03
Percent B (%b) 0.36
BandWidth 7.39
MACD Line 1.84
MACD Signal Line 2.77
MACD Histogram -0.9322
Fundamentals Value
Market Cap 148.57 Billion
Num Shares 1.05 Billion
EPS 2.31
Price-to-Earnings (P/E) Ratio 60.97
Price-to-Sales 4.03
Price-to-Book 6.30
PEG Ratio 1.77
Dividend 2.08
Dividend Yield 1.48%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 143.05
Resistance 3 (R3) 143.14 142.49 142.68
Resistance 2 (R2) 142.49 141.92 142.45 142.56
Resistance 1 (R1) 141.66 141.58 141.34 141.57 142.43
Pivot Point 141.01 141.01 140.85 140.97 141.01
Support 1 (S1) 140.18 140.44 139.86 140.09 139.23
Support 2 (S2) 139.53 140.10 139.49 139.10
Support 3 (S3) 138.70 139.53 138.98
Support 4 (S4) 138.61